Alto Neuroscience initiates Phase 2 study of ALTO-101
PremiumThe FlyAlto Neuroscience initiates Phase 2 study of ALTO-101
3M ago
Alto Neuroscience announces Michael Hanley as COO
Premium
The Fly
Alto Neuroscience announces Michael Hanley as COO
4M ago
Alto Neuroscience reports Q1 EPS (76c), consensus (46c)
Premium
The Fly
Alto Neuroscience reports Q1 EPS (76c), consensus (46c)
4M ago
Alto Neuroscience falls -11.1%
PremiumThe FlyAlto Neuroscience falls -11.1%
6M ago
Premium
Company Announcements
Alto Neuroscience Welcomes Dr. Radhakrishnan to Board
6M ago
Analysts Bet Big on These Beaten-Down IPO Stocks
Premium
Stock Analysis & Ideas
Analysts Bet Big on These Beaten-Down IPO Stocks
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100